4//SEC Filing
OSBORNE DAVID W 4
Accession 0001567619-21-005731
CIK 0001787306other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 3:52 PM ET
Size
7.5 KB
Accession
0001567619-21-005731
Insider Transaction Report
Form 4
OSBORNE DAVID W
Chief Technical Officer
Transactions
- Award
Common Stock
2021-03-03+9,500→ 246,753 total - Award
Stock Option (Right to Buy)
2021-03-03+28,800→ 28,800 totalExercise: $32.44Exp: 2031-03-03→ Common Stock (28,800 underlying)
Footnotes (3)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 3 of each year, beginning March 3, 2022, subject to the Reporting Person's continued service to the Issuer.
- [F2]Includes 16,250 RSUs.
- [F3]1/48th of the shares subject to the option vest on each monthly anniversary measured from March 3, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001252999
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 3:52 PM ET
- Size
- 7.5 KB